Leah Rosenbaum, Forbes Staff

Author's posts

Vaccine Company Novavax Gets $388 Million Grant For Coronavirus Vaccine

CEPI, the Coalition for Epidemic Preparedness, has promised the company up to a total of $392 for the development of a vaccine against the COVID-19 coronavirus.

Fueled By $500 Million In Federal Cash, Moderna Races To Make 1 Billion Doses Of An Unproven Cure

The company’s billionaire CEO has secured huge grants on the promise of a new class of mRNA vaccines, but nobody really knows if they will work.

As Coronavirus Spreads Globally, These Researchers Are Designing Ventilators That Cost Less Than $1,000

Academic groups across the U.S. are creating low-cost ventilators. Who will use them?

This Startup’s ‘Liquid Biopsy’ May Help Find Previously Undetected Cancers

The study was the first of its kind, but researchers caution this technology needs to be used in conjunction with other methods for best results.

Johns Hopkins Changed Its Guidance On Re-Opening The Economy After Pushback From Librarians

Librarians online voiced displeasure at the Hopkins report which classified libraries as low risk for coronavirus transmission.

HIV And Flu Drugs Prove Futile In Fight Against Coronavirus

Kaletra and Arbidol, drugs used to fight HIV and flu infections, show no effect in coronavirus patients in new clinical trial

Rockefeller Foundation Announces National Coronavirus Testing Plan With $15 Million Investment

Experts from the foundation say they want the capacity for 30 million tests per week within 6 months.

New Hopkins Report Offers Guidance To Ease State Coronavirus Lockdowns

Parks and libraries may be less risky to open than schools and airplanes.

This 30 Under 30 Alum Is Figuring Out How Many People Already Have Immunity Against Coronavirus

Kaitlyn Sadtler is leading the National Institute of Health’s coronavirus serologic survey.

EXCLUSIVE: Livongo Helps Hospital Staff Go Hands-Free To Help Diabetic Coronavirus Patients

Digital health company Livongo received emergency authorization from the FDA for remote glucose monitoring in hospitals